Nonmuscle invasive bladder cancer: a primer on immunotherapy

Intravesical Bacillus Calmette-Guérin (BCG) has long been the gold standard treatment of nonmuscle invasive bladder cancer. Recently, there has been an emergence of novel immunotherapeutic agents, which have shown promise in the treatment of urothelial cell carcinoma. These agents aim to augment, mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruf, Mahir, Brancato, Sam J., Agarwal, Piyush K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944546/
https://www.ncbi.nlm.nih.gov/pubmed/27458527
http://dx.doi.org/10.20892/j.issn.2095-3941.2016.0020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944546/
https://www.ncbi.nlm.nih.gov/pubmed/27458527
http://dx.doi.org/10.20892/j.issn.2095-3941.2016.0020

Ejemplares similares